Texas Permanent School Fund Corp Has $1.45 Million Holdings in Waters Corporation $WAT

Texas Permanent School Fund Corp lessened its position in Waters Corporation (NYSE:WAT) by 36.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,150 shares of the medical instruments supplier’s stock after selling 2,425 shares during the quarter. Texas Permanent School Fund Corp’s holdings in Waters were worth $1,449,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. IFP Advisors Inc lifted its holdings in shares of Waters by 65.4% in the second quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 53 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in Waters during the second quarter valued at $53,000. MUFG Securities EMEA plc purchased a new stake in Waters in the 2nd quarter worth about $61,000. Creative Financial Designs Inc. ADV lifted its stake in Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after acquiring an additional 160 shares in the last quarter. Finally, Steph & Co. acquired a new stake in Waters during the 2nd quarter worth about $73,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wolfe Research raised shares of Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price target for the company in a research report on Wednesday, December 10th. Redburn Partners set a $390.00 target price on shares of Waters in a research report on Wednesday, October 8th. Wells Fargo & Company lifted their target price on shares of Waters from $385.00 to $415.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. JPMorgan Chase & Co. upped their price target on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Finally, Rothschild & Co Redburn began coverage on Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $392.19.

Waters Stock Performance

Shares of WAT opened at $383.17 on Wednesday. The firm has a market cap of $22.82 billion, a price-to-earnings ratio of 35.22, a price-to-earnings-growth ratio of 3.49 and a beta of 1.16. The company’s fifty day moving average is $375.44 and its 200-day moving average is $334.95. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $608.55 million during the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. Equities analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.